The letter highlighted the most important provisions of the legislation, including:
- Use of a health-based standard to assess chemical safety and explicitly require protection of the most vulnerable populations, including children, workers, minority communities and low-income groups;
- Prohibition against the introduction of new chemicals without a finding that the substance meets the applicable safety standard and is not a known or suspected reproductive, developmental, neurological, or immunological toxicant, carcinogen, mutagen, or endocrine disruptor;
- Directing the Environmental Protection Agency (EPA) to prioritize those chemicals of particular hazard to the public for immediate risk management;
- Requiring chemical manufacturers to bear the burden of proving that chemical substances meet applicable safety standards;
- Ensuring that workers, communities, and the public have a right to know information regarding their chemical exposure;
- Requiring federal agency coordination to avoid overlapping responsibilities for protecting Americans’ occupational and environmental health;
- Providing federal support for basic and applied research, and incentives for the production of safer alternatives to hazardous substances currently in use.